The Food and Drug Administration has approved Ozempic ® (semaglutide) to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, and cardiovascular ...

A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.

GLP-1 agonists like Ozempic, Trulicity, Mounjaro, Victoza, Wegovy started as a way to treat diabetes but have since become popular for weight loss.

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds were identified using a virtual screening approach.

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different ...

today announced that the first patient has been dosed in the OCU200 Phase 1 clinical trial for diabetic macular edema (DME). “OCU200 has the potential to change the treatment landscape for DME ...

A study conducted by Rivia, a network of tech-driven primary care clinics, from data collected in 2024, has indicated that Ghana is experiencing a rise in "silent" killer diseases. According to ...

"Our study shows that the addition of semaglutide can help them better manage the disease." In type 1 diabetes, the pancreas is unable to produce insulin, a hormone that regulates glucose levels.

The data revealed that 2.2 million new cases of type 2 diabetes and 1.2 million new cases of heart disease could be attributed to sugar-sweetened beverages each year. That means the drinks ...

A motorist charged with causing the deaths of a father and son in a head-on collision was using a Portuguese driving licence obtained while previously banned from Northern Ireland’s roads, the ...